Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 260.60
+9.29 (3.70%)
Apr 6, 2026, 3:29 PM IST
Gujarat Themis Biosyn Market Cap
Gujarat Themis Biosyn has a market cap or net worth of 28.45 billion as of April 6, 2026. Its market cap has increased by 5.50% in one year.
Market Cap
28.45B
Enterprise Value
29.06B
Revenue
1.59B
Ranking
n/a
PE Ratio
59.52
Stock Price
260.60
Market Cap Chart
Since January 2, 2002, Gujarat Themis Biosyn's market cap has increased from 34.80M to 28.45B, an increase of 81,639.81%. That is a compound annual growth rate of 31.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 27.40B | -43.16% |
| Dec 31, 2025 | 48.21B | 44.85% |
| Dec 31, 2024 | 33.28B | 78.59% |
| Dec 29, 2023 | 18.64B | 65.76% |
| Dec 30, 2022 | 11.24B | 62.30% |
| Dec 31, 2021 | 6.93B | 89.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 58.53B |
| Innova Captab | 40.31B |
| Sun Pharma Advanced Research Company | 40.26B |
| RPG Life Sciences | 31.77B |
| Orchid Pharma | 26.57B |
| Solara Active Pharma Sciences | 22.93B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.11B |